Piramal Alternatives Invests INR 160 Cr in Sai Mirra Innopharm
Sai Mirra Innopharm, a leading pharmaceutical company headquartered in Chennai, has secured INR 160 crore in funding from Piramal Alternatives, the fund management arm of the Piramal Group. The investment was made through the India Credit Opportunities Fund II (PCF II), a sector-agnostic vehicle targeting mid-market corporates. Third Investment by PCF II This funding marks … Read more